These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30447705)

  • 1. Glycemic Variability: How to Measure and Its Clinical Implication for Type 2 Diabetes.
    Umpierrez GE; P Kovatchev B
    Am J Med Sci; 2018 Dec; 356(6):518-527. PubMed ID: 30447705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of Traditional and Risk-Based Glycemic Variability Measures to the Effect of Glucose-Lowering Treatment in Type 2 Diabetes Mellitus.
    Kovatchev B; Umpierrez G; DiGenio A; Zhou R; Inzucchi SE
    J Diabetes Sci Technol; 2015 Jun; 9(6):1227-35. PubMed ID: 26078255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic Variability and Diabetes Complications: Does It Matter? Simply Put, There Are Better Glycemic Markers!
    Bergenstal RM
    Diabetes Care; 2015 Aug; 38(8):1615-21. PubMed ID: 26207055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.
    Swami V; Yadav SK; Saxena P; Sharma A; Dash CK; Gupta A
    J Assoc Physicians India; 2024 Jan; 72(1):18-21. PubMed ID: 38736069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
    Hirsch IB
    Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycemic variability and cardiovascular disease in patients with type 2 diabetes.
    Martinez M; Santamarina J; Pavesi A; Musso C; Umpierrez GE
    BMJ Open Diabetes Res Care; 2021 Mar; 9(1):. PubMed ID: 33762313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.
    Shivaprasad C; Aiswarya Y; Kejal S; Sridevi A; Anupam B; Ramdas B; Gautham K; Aarudhra P
    J Diabetes Sci Technol; 2021 Jan; 15(1):134-140. PubMed ID: 31282179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
    Guelho D; Paiva I; Batista C; Barros L; Carrilho F
    Minerva Endocrinol; 2014 Jun; 39(2):127-33. PubMed ID: 24736487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED HEMOGLOBIN A1C.
    Shaefer C; Reid T; Vlajnic A; Zhou R; DiGenio A
    Endocr Pract; 2015 Dec; 21(12):1323-32. PubMed ID: 26307902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin A1c and Permissive Hyperglycemia in Patients in the Intensive Care Unit with Diabetes.
    Balintescu A; Mårtensson J
    Crit Care Clin; 2019 Apr; 35(2):289-300. PubMed ID: 30784610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study.
    Kar P; Plummer MP; Bellomo R; Jenkins AJ; Januszewski AS; Chapman MJ; Jones KL; Horowitz M; Deane AM
    Crit Care Med; 2016 Sep; 44(9):1695-703. PubMed ID: 27315191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic Kidney Disease: Is There a Role for Glycemic Variability?
    Subramanian S; Hirsch IB
    Curr Diab Rep; 2018 Feb; 18(3):13. PubMed ID: 29450720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Glycemic Variability in Diabetes Mellitus.
    Kusunoki Y; Konishi K; Tsunoda T; Koyama H
    Intern Med; 2022 Feb; 61(3):281-290. PubMed ID: 34544956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing glycemic variation: why, when and how?
    Cameron FJ; Baghurst PA; Rodbard D
    Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():432-44. PubMed ID: 20877258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Switching from Degludec to Glargine U300 in Patients with Insulin-Dependent Type 1 Diabetes: A Retrospective Study.
    Sawamura T; Karashima S; Ohbatake A; Higashitani T; Ohmori A; Sawada K; Yamamoto R; Kometani M; Katsuda Y; Yoneda T
    Medicina (Kaunas); 2024 Mar; 60(3):. PubMed ID: 38541176
    [No Abstract]   [Full Text] [Related]  

  • 16. Defining High Glycemic Variability in Type 1 Diabetes: Comparison of Multiple Indexes to Identify Patients at Risk of Hypoglycemia.
    Gómez AM; Henao DC; Imitola Madero A; Taboada LB; Cruz V; Robledo Gómez MA; Rondón M; Muñoz-Velandia O; García-Jaramillo M; León Vargas FM
    Diabetes Technol Ther; 2019 Aug; 21(8):430-439. PubMed ID: 31219350
    [No Abstract]   [Full Text] [Related]  

  • 17. Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study.
    Del Olmo-García MI; Hervás Marín D; Caudet Esteban J; Ballesteros Martin-Portugués A; Cerveró Rubio A; Arnau Vives MA; Catalá Gregori A; Penalba Martínez M; Merino-Torres JF
    J Int Med Res; 2020 Jun; 48(6):300060520926063. PubMed ID: 32567433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond HbA1c.
    Bloomgarden Z
    J Diabetes; 2017 Dec; 9(12):1052-1053. PubMed ID: 28792665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the mean absolute glucose change as a measure of glycemic variability using continuous glucose monitoring data.
    Kohnert KD; Heinke P; Fritzsche G; Vogt L; Augstein P; Salzsieder E
    Diabetes Technol Ther; 2013 Jun; 15(6):448-54. PubMed ID: 23550553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment.
    Miya A; Nakamura A; Handa T; Nomoto H; Kameda H; Cho KY; Nagai S; Miyoshi H; Atsumi T
    J Diabetes Investig; 2021 May; 12(5):738-746. PubMed ID: 33021063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.